Genmab
GMAB
237 hedge funds and large institutions have $1.94B invested in Genmab in 2022 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 75 increasing their positions, 79 reducing their positions, and 19 closing their positions.
247% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 19
36% more capital invested
Capital invested by funds: $1.43B → $1.94B (+$513M)
23% more funds holding
Funds holding: 193 → 237 (+44)
1.92% more ownership
Funds ownership: 67.5% → 69.42% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 79
25% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $1.45M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$32.9M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$22.9M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$19.6M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$17.8M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$38.3M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$32.9M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$21M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$11.2M |
| 5 |
HJGA
Hardman Johnston Global Advisors
Stamford,
Connecticut
|
-$9.87M |
GMAB Hedge Fund Activity: Q4 2022 in Review
237 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q4 2022, worth a combined $1.94B — up 36% from $1.43B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new GMAB positions and 19 closed out — a net gain of 47 holders — while 75 added to existing stakes and 79 trimmed.
The largest buyer was Millennium Management, adding an estimated $32.9M. The largest seller was Wellington Management Group, cutting an estimated $38.3M.
- 237 institutional investors held Genmab (GMAB) as of Q4 2022, up from 193 in Q3 2022.
- Funds reported $1.94B of Genmab stock for Q4 2022, up 36% quarter-over-quarter.
- 66 funds opened new Genmab positions in Q4 2022 and 19 closed out, a net change of +47 holders.
- The largest Genmab buyer in Q4 2022 was Millennium Management, an estimated $32.9M added.
- The largest Genmab seller in Q4 2022 was Wellington Management Group, an estimated $38.3M sold.
Based on aggregated 13F filings for Q4 2022.